These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1604674)
1. Long-term treatment of type I diabetes in 28 patients using two different implantable programmable pumps. Jeandidier N; Pinget M; Keipes M; Louy S; Charton MN; Marescaux J; Reville P Transplant Proc; 1992 Jun; 24(3):940-1. PubMed ID: 1604674 [No Abstract] [Full Text] [Related]
2. Short-term treatment by implantable pump does not impair lipoprotein pattern in IDDM patients. Hanaire-Broutin H; Lorenzini F; Lacombe S; Lafon F; Solera ML; Tauber JP Transplant Proc; 1992 Jun; 24(3):947. PubMed ID: 1604677 [No Abstract] [Full Text] [Related]
3. Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study. Jeandidier N; Pinget M; Keipes M; Louy S; Vetter A; Réville P Transplant Proc; 1992 Jun; 24(3):948-9. PubMed ID: 1604678 [No Abstract] [Full Text] [Related]
4. The effect of continuous subcutaneous insulin infusion on serum lipids. Lawson P; Trayner I; Rosenstock J; Kohner E Diabete Metab; 1984 Oct; 10(4):239-44. PubMed ID: 6510544 [TBL] [Abstract][Full Text] [Related]
5. Implantable programmable insulin pumps for the treatment of diabetes. Waxman K; Turner D; Nguyen ST; Selam JL; Charles MA Arch Surg; 1992 Sep; 127(9):1032-6; discussion 1036-7. PubMed ID: 1387526 [TBL] [Abstract][Full Text] [Related]
6. [Effects of intensified insulin therapy on fat metabolism in type 1 diabetes mellitus]. Dzien A; Drexel H; Hopferwieser T; Patsch JR; Braunsteiner H Dtsch Med Wochenschr; 1988 Oct; 113(43):1669-72. PubMed ID: 3053082 [TBL] [Abstract][Full Text] [Related]
7. Intensive management of type 1 diabetes in young children. Kaufman FR Lancet; 2005 Feb 26-Mar 4; 365(9461):737-8. PubMed ID: 15733703 [No Abstract] [Full Text] [Related]
8. Clinical trial of programmable implantable insulin pump for type I diabetes. Selam JL; Micossi P; Dunn FL; Nathan DM Diabetes Care; 1992 Jul; 15(7):877-85. PubMed ID: 1516508 [TBL] [Abstract][Full Text] [Related]
9. Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus. Attia N; Touzani A; Lahrichi M; Balafrej A; Kabbaj O; Girard-Globa A Diabet Med; 1997 Mar; 14(3):242-7. PubMed ID: 9088774 [TBL] [Abstract][Full Text] [Related]
10. Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps. Renard E; Lauton D; Bonifacj C; Costalat G; Jacques D; Bringer J; Jaffiol C Diabete Metab; 1993; 19(4):364-71. PubMed ID: 8293863 [TBL] [Abstract][Full Text] [Related]
11. Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study. Szadkowska A; Michalak A; Chylińska-Frątczak A; Baranowska-Jaźwiecka A; Koptas M; Pietrzak I; Hogendorf A; Zmysłowska A; Młynarski W; Mianowska B J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1073-1079. PubMed ID: 30240358 [TBL] [Abstract][Full Text] [Related]
12. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs. Hanaire-Broutin H; Broussolle C; Jeandidier N; Renard E; Guerci B; Haardt MJ; Lassmann-Vague V Diabetes Care; 1995 Mar; 18(3):388-92. PubMed ID: 7555483 [TBL] [Abstract][Full Text] [Related]
13. [Correlation between glycemia control and lipid metabolism parameters in children with diabetes mellitus]. Klinghammer A; Thomser J Kinderarztl Prax; 1993 Jun; 61(4-5):151-3. PubMed ID: 8361144 [TBL] [Abstract][Full Text] [Related]
14. [Diabetes and the insulin pump: functional results after 5 consecutive years of permanent use]. Mirouze J; Rouault R; Misse P; Millet P; Bordat B; Selam JL; Boudet C Bull Soc Ophtalmol Fr; 1989 Mar; 89(3):437-40. PubMed ID: 2598391 [No Abstract] [Full Text] [Related]
15. French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society. Broussolle C; Jeandidier N; Hanaire-Broutin H Lancet; 1994 Feb; 343(8896):514-5. PubMed ID: 7906761 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of adult- compared to childhood-onset type 1 diabetes. Casu A; Kanapka LG; Foster NC; Hirsch IB; Laffel LM; Shah VN; DeSalvo DJ; Lyons SK; Vendrame F; Aleppo G; Mastrandrea LD; Pratley RE; Rickels MR; Peters AL; Diabet Med; 2020 Dec; 37(12):2109-2115. PubMed ID: 32353892 [TBL] [Abstract][Full Text] [Related]
17. Is Pump Therapy for All with Type 1 Diabetes? Wilson DM Diabetes Technol Ther; 2016 May; 18(5):280-1. PubMed ID: 27159783 [No Abstract] [Full Text] [Related]
18. Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia. Ismail IS; Nazaimoon W; Mohamad W; Letchuman R; Singaraveloo M; Hew FL; Shuguna C; Khalid BA Diabet Med; 2001 Jun; 18(6):501-8. PubMed ID: 11472471 [TBL] [Abstract][Full Text] [Related]
19. Increased levels of HDL-cholesterol and apolipoprotein A-I after intensified insulin therapy for diabetes. Wilson DP; Fesmire JD; Endres RK; Blackett PR South Med J; 1985 Jun; 78(6):636-8. PubMed ID: 3923627 [TBL] [Abstract][Full Text] [Related]
20. First experiments in taurine administration for diabetes mellitus. The effect on erythrocyte membranes. Elizarova EP; Nedosugova LV Adv Exp Med Biol; 1996; 403():583-8. PubMed ID: 8915397 [No Abstract] [Full Text] [Related] [Next] [New Search]